Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 895308 | ISIN: US50540R4092 | Ticker-Symbol: LAB
Düsseldorf
03.05.24
19:31 Uhr
185,00 Euro
0,00
0,00 %
Branche
Sonstige Technologie
Aktienmarkt
S&P 500
1-Jahres-Chart
LABORATORY CORPORATION OF AMERICA HOLDINGS Chart 1 Jahr
5-Tage-Chart
LABORATORY CORPORATION OF AMERICA HOLDINGS 5-Tage-Chart
RealtimeGeldBriefZeit
187,00190,0013:04
187,00188,0003.05.

Aktuelle News zur LABORATORY CORP OF AMERICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiLaboratory Corporation of America Holdings (LH) Q1 2024 Earnings Call Transcript2
DiLABORATORY CORP OF AMERICA HOLDINGS - 10-Q, Quarterly Report2
MoLabcorp nets companion diagnostic approval for Pfizer's hemophilia B gene therapy Beqvez4
MoQuest Diagnostics, LabCorp climb following FDA testing oversight rule3
MoLabcorp: FDA Approves NAbCyte Companion Diagnostic239NEW YORK CITY (dpa-AFX) - Labcorp (LH) announced the FDA has approved its nAbCyte Anti-AAVRh74var HB-FE Assay, a companion diagnostic to determine patient eligibility for treatment with BEQVEZ...
► Artikel lesen
MoLabcorp's companion diagnostic approved for use with Pfizer's hemophilia B gene therapy5
MoLabcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B500Assay expands company's leadership in precision medicine and cell and gene therapy BURLINGTON, N.C., April 29, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive...
► Artikel lesen
SoLabcorp Makes Another Acquisition, Plucking Invitae Assets From Bankruptcy Auction9
26.04.Analyst Ratings For Laboratory Corp2
26.04.Labcorp picks up Invitae portfolio for $239M in bankruptcy sale9
25.04.Labcorp's Q1 Revenue Surpasses Forecasts; Analysts Scrutinize Invitae Deal6
25.04.Laboratory Corporation Of America Holdings Q1 Income Climbs, But Misses Estimates179WASHINGTON (dpa-AFX) - Laboratory Corporation Of America Holdings (LH) announced a profit for its first quarter that increased from the same period last year but missed the Street estimates.The...
► Artikel lesen
25.04.Laboratory Corporation of America Holdings reports results for the quarter ended in March - Earnings Summary3
25.04.Labcorp (LH) Tops Q1 Earnings Estimates, Raises 2024 EPS View3
25.04.ROUNDUP: Labcorp Narrows FY24 Outlook Range165WASHINGTON (dpa-AFX) - While reporting financial results for the first quarter on Thursday, life sciences company Labcorp (LH) narrowed adjusted earnings and revenue growth guidance range for...
► Artikel lesen
25.04.Laboratory Corporation Of America Holdings Q1 Income Climbs, but misses estimates181WASHINGTON (dpa-AFX) - Laboratory Corporation Of America Holdings (LH) announced a profit for its first quarter that increased from the same period last year but missed the Street estimates.The...
► Artikel lesen
25.04.Labcorp shares drop despite Q1 earnings beat3
25.04.Labcorp beats quarterly estimates on strong testing demand4
25.04.LABORATORY CORP OF AMERICA HOLDINGS - 8-K, Current Report2
25.04.Laboratory Corporation of America Holdings: Labcorp Announces 2024 First Quarter Results188Updates Full-Year Guidance Results from Continuing Operations for first quarter 2024 versus last year: Revenue: $3.18 billion versus $3.04 billion or up 4.6% | Base Business grew 6.7% Diluted EPS:...
► Artikel lesen
Seite:  Weiter >>
116 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1